Prenosis

Sepsis ImmunoScore™, developed by Prenosis, represents a breakthrough in how medicine can better understand and assess sepsis risk. Rather than relying solely on symptoms, it offers interpretable insight into how each biomarker contributes to a patient’s risk score, revealing who is most at risk of sepsis in the next 24 hours. The FDA De Novo-authorized tool combines biology and AI to bring new clarity to one of healthcare’s most complex challenges. Backed by data from more than 30,000 patients and 100,000 biological samples, Sepsis ImmunoScore points to a new era of biologically driven, precision diagnostics.